亮氨酸拉链
酵母
失调
化学
碱性螺旋-环-螺旋-亮氨酸拉链转录因子
ATF3
糖皮质激素
bZIP域
结肠炎
生物化学
生物
免疫学
转录因子
肠道菌群
DNA结合蛋白
基因
发起人
基因表达
作者
Marco Gentili,Samuele Sabbatini,Emilia Nunzi,Eleonora Lusenti,Luigi Cari,Antonella Mencacci,Nathalie Ballet,Graziella Migliorati,Carlo Riccardi,Simona Ronchetti,Claudia Monari
出处
期刊:Biomolecules
[Multidisciplinary Digital Publishing Institute]
日期:2024-10-17
卷期号:14 (10): 1321-1321
摘要
Inflammatory bowel diseases (IBD) have a complex, poorly understood pathogenesis and lack long-lasting effective treatments. Recent research suggests that intestinal fungal dysbiosis may play a role in IBD development. This study investigates the effects of the glucocorticoid-induced leucine zipper protein (GILZp)", known for its protective role in gut mucosa, and a yeast extract (Py) with prebiotic properties, either alone or combined, in DSS-induced colitis. Both treatments alleviated symptoms via overlapping or distinct mechanisms. In particular, they reduced the transcription levels of pro-inflammatory cytokines IL-1β and TNF-α, as well as the expression of the tight junction protein Claudin-2. Additionally, GILZp increased MUC2 transcription, while Py reduced IL-12p40 and IL-6 levels. Notably, both treatments were effective in restoring the intestinal burden of clinically important Candida and related species. Intestinal mycobiome analysis revealed that they were able to reduce colitis-associated fungal dysbiosis, and this effect was mainly the result of a decreased abundance of the Meyerozima genus, which was dominant in colitic mice. Overall, our results suggest that combined treatment regimens with GILZp and Py could represent a new strategy for the treatment of IBD by targeting multiple mechanisms, including the fungal dysbiosis.
科研通智能强力驱动
Strongly Powered by AbleSci AI